생식기 감염 증상이 있는 폐경 전 여성에서의 Mycoplasmas 감염률 = The incidence of genital Mycoplasmas infection in premenopausal women with gynecologic symptoms

다국어 초록 (Multilingual Abstract)

Objective: This study was to evaluate the incidence of genital Mycoplasmas Infection in Korean premenopausal women with gynecologic symptoms Methods: Between January 2006 and December 2006, vaginal specimens from 90 premenopausal patients with gynecologic symptoms were obtained for analysis of genital Mycoplasmas infection using multiplex PCR. Results: The incidence of M. hominis, U. urealyticum, and M. genitalicum infection was 44.4%, 18.9% and 2.2% respectively. From patients with non-foul odored vaginal discharge, M. hominis, and, U. urealyticum were detected in 37.8% and 17.8% respectively. From patients with bacterial vaginosis who had foul odored vaginal discharge, M. hominis, U. urealyticum, and M. genitalicum were detected in 71.4%, 14.3% and 4.8% respectively. From patients with PID or FHC syndrome, M. hominis, U. urealyticum, and M. genitalicum were detected in 43.8%, 37.5% and 6.3% respectively. Conclusion: The incidence of Mycoplasmas infection from vaginal specimens of Korean premenopausal women with gynecologic symptoms was about 66%. Especially, 56% of patients with non-foul odored vaginal discharge, 90% with bacterial vaginosis, and 88% with PID or FHC syndrome showed Mycoplasmas infection, so we suggest the consideration of Mycoplasmas infection as cause of gynecologic symptoms.

참고문헌 (Reference)

1 김소영, "조산모와 조기 양막파수에서 Mycoplasma Hominis와 Ureaplasma Urealyticum의 감염율 분석" 대한산부인과학회 47 (47): 1469-1473, 2004

2 윤보현, "조기분만 진통 산모에서 양수 내감염의 발생 양상 및 임상적 의의" 37 : 1338-1349, 1994

3 이해혁, "여성 생식기 염증에서 Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum의 검출" 42 : 549-555, 1999

4 안희성, "산부인과 영역에서의 마이코프라스마 호미니스 감염에 관한 연구" 32 : 1503-1509, 1989

5 Spence D, "Vaginal discharge" 335 : 1147-1151, 2007

6 Taylor-Robinson D, "The genital mycoplasmas (first of two parts)" 302 : 1003-1010, 1980

7 Kundsin RB, "Strain of mycoplasma associated with human reproductive failure" 157 : 1573-1574, 1967

8 Homer PJ, "National guideline for the management of genital tract infection with Chlamydia trachomatis" Clinical Effectiveness group. British Association for Sexual Health and HIV

9 Chang MW, "Isolation of Ureaplasma urealyticum and Mycoplasma hominis from patients with genitourinary tract infection" 33 : 53-56, 1984

10 Arya OP, "Is mycoplasma hominis a vaginal pathogen" 77 : 58-62, 2001

11 Shaw C, "Group B streptococcus carriage and vulvovaginal symptoms: causal or casual? A case-control study in a GUM clinic population" 79 : 246-248, 2003

12 Kent HL, "Epidemiology of vaginitis" 165 (165): 1168-1176, 1991

13 Ullmann U, "Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis" 43 (43): 33-36, 1999

14 Klein JO, "Colonization of newborn infants by mycoplasmas" 280 : 1025-1030, 1969

15 Jonathan S, "Berek. Berek & Novak’s Gyneocology, In Genitourinary infections and sexually transmitted disease. 14th ed" Lippincott Williams & Wilkins 541-559,

16 Kundsin RB, "Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality" 310 : 941-945, 1984

17 Mulley AG, "Approach to the patient with a vaginal discharge, In Primary Care Medicine: Office Evaluation and Management of the Adult Patient" Lippincott Williams & Wilkns 702-707, 2000

18 Mårdh PA, "Antibodies to Mycoplasma hominis in patients with genital infections and in healthy controls" 46 : 390-397, 1970

19 Mårdh PA, "-mycoplasmas in the genito-urinary tract of the female" 78 : 367-374, 1970